We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$17.9B
AUM Growth
+$1.14B
Cap. Flow
+$898M
Cap. Flow %
5.03%
Top 10 Hldgs %
20.79%
Holding
1,733
New
108
Increased
875
Reduced
669
Closed
77

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.3M
2
AMZN icon
Amazon
AMZN
+$30.2M
3
AOS icon
A.O. Smith
AOS
+$28.2M
4
MMM icon
3M
MMM
+$25M
5
ABBV icon
AbbVie
ABBV
+$24.1M

Sector Composition

Rank Sector Weight
1 Technology 19.26%
2 Financials 12.67%
3 Consumer Staples 11.59%
4 Industrials 11.46%
5 Healthcare 11.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLCA
1551
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$98K ﹤0.01%
10,213
-4,304
-30% -$49.6K
FIT
1552
DELISTED
Fitbit, Inc. Class A common stock
FIT
$98K ﹤0.01%
25,607
+2,941
+13% +$10.9K
HL icon
1553
Hecla Mining
HL
$10.1B
$97K ﹤0.01%
54,884
+6,325
+13% +$11.4K
CMO
1554
DELISTED
Capstead Mortgage Corp.
CMO
$96K ﹤0.01%
13,082
+1,631
+14% +$13.1K
WT icon
1555
WisdomTree
WT
$2.98B
$95K ﹤0.01%
18,167
+2,391
+15% +$13.5K
NPKI
1556
NPK International
NPKI
$1.2B
$95K ﹤0.01%
12,413
+366
+3% +$2.59K
GERN icon
1557
Geron
GERN
$924M
$94K ﹤0.01%
70,910
-1,686
-2% -$2.26K
PDLI
1558
DELISTED
PDL BioPharma, Inc.
PDLI
$94K ﹤0.01%
43,749
-6,294
-13% -$16.8K
MCRB icon
1559
Seres Therapeutics
MCRB
$48.9M
$93K ﹤0.01%
1,154
+445
+63% +$29.4K
NBR icon
1560
Nabors Industries
NBR
$1.23B
$92K ﹤0.01%
985
+414
+73% +$46.6K
ACIU icon
1561
AC Immune
ACIU
$224M
$91K ﹤0.01%
18,290
-1,428
-7% -$7.65K
MNKD icon
1562
MannKind Corp
MNKD
$1.29B
$91K ﹤0.01%
72,689
+571
+0.8% +$665
UBX
1563
DELISTED
Unity Biotechnology
UBX
$90K ﹤0.01%
1,474
-42
-3% -$2.97K
FTSV
1564
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$90K ﹤0.01%
13,960
+3,326
+31% +$27.3K
TELL
1565
DELISTED
Tellurian Inc.
TELL
$89K ﹤0.01%
+10,758
New +$77.2K
TROX icon
1566
Tronox
TROX
$999M
$86K ﹤0.01%
+10,399
New +$100K
SYRE icon
1567
Spyre Therapeutics
SYRE
$8.75B
$83K ﹤0.01%
432
+14
+3% +$2.73K
HLIT icon
1568
Harmonic Inc
HLIT
$1.21B
$81K ﹤0.01%
12,313
+757
+7% +$5.24K
CLVS
1569
DELISTED
Clovis Oncology, Inc.
CLVS
$81K ﹤0.01%
20,532
-1,272
-6% -$10.3K
CISN
1570
DELISTED
Cision Ltd. Ordinary Share
CISN
$80K ﹤0.01%
+10,431
New +$89.8K
TCRT icon
1571
Alaunos Therapeutics
TCRT
$4.71M
$78K ﹤0.01%
122
+29
+31% +$23K
DNR
1572
DELISTED
Denbury Resources, Inc.
DNR
$78K ﹤0.01%
65,225
+3,266
+5% +$3.77K
INO icon
1573
Inovio Pharmaceuticals
INO
$79.3M
$77K ﹤0.01%
3,114
-40
-1% -$1.22K
GPRO icon
1574
GoPro
GPRO
$115M
$74K ﹤0.01%
14,346
+2,173
+18% +$10.2K
PLUG icon
1575
Plug Power
PLUG
$2.92B
$71K ﹤0.01%
26,891
+4,240
+19% +$9.83K

Similar funds

ProShare Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, ProShare Advisors held 1,733 positions worth $17.9B, up 6.8% from $16.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

ProShare Advisors deployed $898M of net new capital in Q3 2019, opening 108 new positions and adding to 875 existing holdings. Its largest new stake was Westwood Holdings Group: 398,825 shares worth $11M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Compass Minerals, an estimated $11.7M trimmed.

  • ProShare Advisors's largest Q3 2019 buy was Westwood Holdings Group: 398,825 shares worth $11M.
  • ProShare Advisors added most to Microsoft in Q3 2019, an estimated $31.3M increase.
  • ProShare Advisors's biggest Q3 2019 reduction was Compass Minerals, cutting an estimated $11.7M.
  • ProShare Advisors fully exited Bank of Marin Bancorp in Q3 2019, selling an estimated $10.6M.
  • ProShare Advisors's ten largest holdings make up 21% of its $17.9B portfolio in Q3 2019.
  • ProShare Advisors opened 108 new positions and closed 77 in Q3 2019.
  • ProShare Advisors's portfolio value rose 6.8% quarter-over-quarter to $17.9B.

Based on ProShare Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.